Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222896 · ClinicalTrials.gov registry record · Phase 3
Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects
A Phase 3 study of Surgery, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 3
- Development phase
- 347
- Enrollment target
- 1
- Study location
NCT02222896 is a Phase 3 study of Surgery that has completed, run by Medline Industries. The registered enrollment target is 347 participants, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02222896, a Phase 3 study of Surgery, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 347 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.
Conditions Studied
Interventions
- OTHER Vehicle
- DRUG Chlorhexidine Gluconate
- DRUG DynaHex-2
Study Locations (1)
Virginia
- MBT - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02222896
The ClinicalTrials.gov registry entry for NCT02222896 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 3 interventions - of which Vehicle is the first listed.
NCT02222896 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02222896 about?
NCT02222896 is a clinical study titled "Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects". Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.
What is the current status of trial NCT02222896?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 347 participants. The study started on 2014-08. Estimated completion is 2015-05.
What conditions does trial NCT02222896 study?
This clinical trial studies the following conditions: Surgery.
What interventions are being tested in trial NCT02222896?
The interventions under investigation include: Vehicle (OTHER), Chlorhexidine Gluconate (DRUG), DynaHex-2 (DRUG).
Who is sponsoring clinical trial NCT02222896?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02222896 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Sentinel Node Biopsy in Endometrial Cancer
RECRUITING · Phase 3
-
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
RECRUITING · Phase 3
-
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo
ACTIVE NOT RECRUITING · Phase 3
-
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.